SeshasaiSRWijesuriyaSSivakumaranR. Effect of aspirin on vascular and nonvascular outcomes:
meta-analysis of randomized controlled trials. Arch Intern
Med.
2012;172(3):209-216.
2.
Antithrombotic Trialists Collaboration. Collaborative
meta-analysis of randomised trials of antiplatelet therapy for prevention of death,
myocardial infarction, and stroke in high risk patients.
BMJ.
2002;324(7329):71-86.
3.
BernardGRVincentJLLaterrePF. Efficacy and safety of recombinant human activated protein
C for severe sepsis. N Engl J Med.
2001;344(10):699-709.
4.
van ZantenARHofmanZHeylandDK. Consequences of the REDOXS and METAPLUS trials: the end of
an era of glutamine and antioxidant supplementation for critically ill
patients?. JPEN J Parenter Enteral Nutr.
2015;39(8):890-892.
5.
HeylandDMuscedereJWischmeyerPE. A randomized trial of glutamine and antioxidants in
critically ill patients. N Engl J Med.
2013;368(16):1489-1497.
6.
van ZantenARSztarkFKaisersUX. High-protein enteral nutrition enriched with
immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial
infections in the ICU: a randomized clinical trial.
JAMA.
2014;312(5):514-524.
7.
PetersRJMehtaSRFoxKA. Effects of aspirin dose when used alone or in combination
with clopidogrel in patients with acute coronary syndromes: observations from the
Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Circulation.
2003;108(14):1682-1687.
8.
WischmeyerPE. Glutamine: role in critical illness and ongoing clinical
trials. Curr Opin Gastroenterol.
2008;24(2):190-197.
9.
WischmeyerPEDhaliwalRMcCallMZieglerTRHeylandDK. Parenteral glutamine supplementation in critical illness:
a systematic review. Crit Care.
2014;18(2):R76.
10.
DéchelottePHasselmannMCynoberL. L-alanyl-L-glutamine dipeptide-supplemented total
parenteral nutrition reduces infectious complications and glucose intolerance in
critically ill patients: the French controlled, randomized, double-blind, multicenter
study. Crit Care Med.
2006;34:598-604.
11.
WernermanJKirketeigTAnderssonB. Scandinavian glutamine trial: a pragmatic multi-centre
randomised clinical trial of intensive care unit patients. Acta
Anaesthesiol Scand.
2011;55:812-818.
BollhalderLPfeilAMTomonagaYSchwenkglenksM. A systematic literature review and meta-analysis of
randomized clinical trials of parenteral glutamine supplementation.
Clin Nutr.
2013;32(2):213-223.
14.
KuhnKSMuscaritoliMWischmeyerPStehleP. Glutamine as indispensable nutrient in oncology:
experimental and clinical evidence. Eur J Nutr.
2010;49(4):197-210.
HeylandDKElkeGCookD. Glutamine and antioxidants in the critically ill patient:
a post hoc analysis of a large-scale randomized trial. JPEN J
Parenter Enteral Nutr.
2015;39(4):401-409.
17.
HeylandDKDhaliwalmRDayADroverJCoteHWischmeyerP. Optimizing the dose of glutamine dipeptides and
antioxidants in critically ill patients: a phase I dose-finding study.
JPEN J Parenter Enteral Nutr.
2007;31(2):109-118.
18.
Oudemans-van StraatenHMBosmanRJTreskesMvan der SpoelHJZandstraDF. Plasma glutamine depletion and patient outcome in acute
ICU admissions. Intensive Care Med.
2001;27(1):84-90.
19.
RodasPCRooyackersOHerbertCNorbergAWernermanJ. Glutamine and glutathione at ICU admission in relation to
outcome. Clin Sci (Lond).
2012;122:591-597.
20.
XueHRenWDenkingerMSchlotzerEWischmeyerPE. Nutrition modulation of cardiotoxicity and anticancer
efficacy related to doxorubicin chemotherapy by glutamine and ω-3 polyunsaturated fatty
acids [published online April17, 2015]. JPEN J Parenter Enteral
Nutr.
21.
RiceTWWheelerAPThompsonBTdeBoisblancBPSteingrubJRockP. Enteral omega-3 fatty acid, gamma-linolenic acid, and
antioxidant supplementation in acute lung injury. JAMA.
2011;306(14):1574-1581.
22.
WischmeyerPEWeitzelLMercaldiK. Characteristics and current practice of parenteral
nutrition in hospitalized patients. JPEN J Parenter Enteral
Nutr.
2013;37(1):56-67.
